SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-044292
Filing Date
2019-09-11
Accepted
2019-09-11 18:48:26
Documents
1
Period of Report
2019-09-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv529267_4.html 4  
1 OWNERSHIP DOCUMENT tv529267_4.xml 4 4472
  Complete submission text file 0001144204-19-044292.txt   6088
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 1100 MAXWELL, #522 HOBOKEN NJ 07030
Business Address
Goel Shubh (Reporting) CIK: 0001787942 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 191089245